Evotec (ETR:EVT) Shares Down 4% – Here’s What Happened

Evotec SE (ETR:EVT) fell 4% on Thursday . The company traded as low as €8.04 ($8.29) and last traded at €8.20 ($8.45). 1,138,303 shares traded hands during trading, a decline of 16% from the average session volume of 1,360,000 shares. The stock had previously closed at €8.54 ($8.80).

Evotec Stock Performance

The firm has a 50 day moving average price of €8.47 and a two-hundred day moving average price of €7.59. The company has a market capitalization of $1.46 billion, a P/E ratio of -8.54, a price-to-earnings-growth ratio of 0.98 and a beta of 1.05. The company has a debt-to-equity ratio of 46.81, a quick ratio of 2.97 and a current ratio of 1.83.

About Evotec

Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as autoimmune diseases, cancer, CNS diseases, diabetes, fibrosis, immunology, infectious diseases, kidney diseases, liver diseases, pain and inflammation, rare diseases, respiratory diseases, tuberculosis, and women's health.